Research
Hormonal
Tirzepatide has been approved for the treatment of adults with type 2 diabetes who are overweight/obese or have weight-related comorbidities.
Tirzepatide is a viable treatment option for managing type 2 diabetes in specific patient populations.
StrongSupportsmedium confidence
Tirzepatide...has been approved for the treatment of adults with type 2 diabetes, and who are overweight/obese or who have weight-related comorbidities.
Why this rating
Based on regulatory approval information.
Source
Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectives
Stefano Fiorucci et al. · Expert Opinion on Investigational Drugs · 2025
rctCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →